-
Prospect Capital Shares Volatile Following Negative Report From SIRF's Roddy Boyd
Monday, August 8, 2016 - 3:14pm | 470The Southern Investigative Reporting Foundation (SIRF)'s Roddy Boyd published on Monday a scathing report on Prospect Capital Corporation (NASDAQ: PSEC), a non-diversified closed-end investment company. The report initially sent shares tumbling to an intra-day low of $8.08, but shares since...
-
Roddy Boyd Nailed Insys Therapeutics Thesis
Wednesday, April 13, 2016 - 2:02pm | 279Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged on Monday after the company provided preliminary first-quarter results. Insys Therapeutics, a specialty pharmaceutical company that develops supportive care products, announced that it expects its first-quarter revenue to fall in a range of $...
-
What's Going On With Insys Therapeutics?
Friday, December 4, 2015 - 9:22am | 714Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged more than 18 percent on Thursday. Roddy Boyd of SIRF wrote a scathing research report on Thursday titled "Murder Incorporated: Insys Therapeutics" in which he argued the company is ‘in a great deal of trouble.'...